Nishimoto K, Sasaki K, Yamamura T, Ishikawa I, Shinoda A
Department of Ophthalmology, Kanazawa Medical University, Ishikawa, Japan.
Lens Eye Toxic Res. 1992;9(3-4):455-67.
Post surgical cataracts induced by corticosteroids as immunosuppressive agents were investigated in recipients undergoing triple therapy with ciclosporin and the results were compared with those who had therapy without ciclosporin administration. The subjects of the triple therapy group were 54 cases with a mean age of 31.7 years. The mean observation period was 25 months. The incidence of posterior subcapsular cataract was 77.8%. 7.9% of them developed progressed cataract. Early cataractous changes were noticed within one post-operative year in half of the cases. 3 out of 22 cases that were followed up over three years showed progressed cataractous changes. The total doses of methylprednisolone during the period of the first post-transplant year in recipients with Grades I or II and over Grade III were 7.7 +/- 1.9g and 9.8 +/- 3.6g, respectively. They were significantly higher than those in the conventional therapy group. However, a 2 to 3 g reduction in the total dose of steroids during the first year had no influence on cataract occurrence.
对接受环孢素三联疗法的受者中由作为免疫抑制剂的皮质类固醇引起的术后白内障进行了研究,并将结果与未给予环孢素治疗的受者进行了比较。三联疗法组的研究对象为54例,平均年龄31.7岁。平均观察期为25个月。后囊下白内障的发生率为77.8%。其中7.9%发展为进行性白内障。半数病例在术后1年内出现早期白内障改变。在随访3年以上的22例病例中,有3例出现进行性白内障改变。移植后第一年,I级或II级及III级以上受者甲基强的松龙的总剂量分别为7.7±1.9g和9.8±3.6g。它们显著高于传统治疗组。然而,第一年类固醇总剂量减少2至3g对白内障的发生没有影响。